maxidex sterile ophthalmic ointment 0.1%
novartis (singapore) pte ltd - dexamethasone - ointment - 0.1% with 3% overage - dexamethasone 0.1%
maxidex sterile ophthalmic suspension 0.1%
novartis (singapore) pte ltd - dexamethasone - solution - 0.10% - dexamethasone 0.1%
maxidex
s.a alcon-couvreur n.v. - dexamethasone 1 mg/ml - eye drops, suspension
ozurdex
abbvie deutschland gmbh & co. kg - dexamethasone - macular edema; uveitis - ophthalmologicals, other ophthalmologicals - ozurdex is indicated for the treatment of adult patients with macular oedema following either branch retinal-vein occlusion (brvo) or central retinal-vein occlusion (crvo).ozurdex is indicated for the treatment of adult patients with inflammation of the posterior segment of the eye presenting as noninfectious uveitis.ozurdex is indicated for the treatment of adult patients with visual impairment due to diabetic macular oedema (dme) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy.
dexamethasone 1% eye drops preservative free
special order - dexamethasone - eye drops - 10mg/1ml
dexamethasone 0.1% eye drops preservative free
special order - dexamethasone sodium phosphate - eye drops - 1mg/1ml
dexamethasone 0.1% eye drops
special order - dexamethasone - eye drops - 1mg/1ml
oftan dexamethason drops eye
santen oy - dexamethasone (dexamethasone sodium phosphate) - drops eye - 1mg/ml
maxidex 1 mg/ml eye drops, suspension
novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - dexamethasone - eye drops, suspension - dexamethasone 1 mg/ml - ophthalmologicals
dexamethasone phosphate newline pharma 1.37 mg/ml eye drops, solution in single dose container
newline pharma, s.l. - dexamethasone phosphate - eye drops, solution in single-dose container - 1.37 milligram(s)/millilitre - dexamethasone